TransPerfect Life Sciences Hosts “Conversations on Clinical Content” Event Series
TransPerfect Life Sciences , a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced a final call for registration for the 2022 Conversations on Clinical Content (C3) summit.
- TransPerfect Life Sciences , a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced a final call for registration for the 2022 Conversations on Clinical Content (C3) summit.
- The event is the third in a three-part series and takes place on October 20 in Princeton, NJ.
- C3 brings together leading industry executives with expertise in product development and decentralized clinical trials (DCTs) for regional meetings and virtual sessions.
- TransPerfect Life Sciences specializes in supporting global development and commercialization of drugs, treatments, and devices designed to improve and save lives.